CSIMarket
 
Tff Pharmaceuticals Inc   (TFFP)
Other Ticker:  
 
 
Price: $7.3700 $-0.25 -3.281%
Day's High: $7.9 Week Perf: -13.29 %
Day's Low: $ 7.30 30 Day Perf: 9.84 %
Volume (M): 10 52 Wk High: $ 21.25
Volume (M$): $ 75 52 Wk Avg: $9.92
Open: $7.75 52 Wk Low: $4.55



 Market Capitalization (Millions $) 14
 Shares Outstanding (Millions) 2
 Employees -
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -14
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 2

Tff Pharmaceuticals Inc
Tff Pharmaceuticals Inc is a pharmaceutical company that focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology. TFF technology provides enhanced drug delivery solutions for various therapeutic areas such as lung diseases, ophthalmic disorders, and rare diseases. The company aims to improve patient outcomes by delivering drugs more effectively and efficiently.


   Company Address: 1751 River Run Fort Worth 76107 TX
   Company Phone Number: 438-6168   Stock Exchange / Ticker: NASDAQ TFFP
   TFFP is expected to report next financial results on March 30, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Clinical Study

TFF Pharmaceuticals Unveils Triumphs: Groundbreaking Phase 2 Trial Results Set to Revolutionize Drug Delivery

Published Mon, Dec 18 2023 9:01 PM UTC

TFF Pharmaceuticals: Unveiling Promising Phase 2 Trial Results for TFF VORI and TFF TAC
TFF Pharmaceuticals, a cutting-edge pharmaceutical company at the forefront of novel drug delivery solutions, is scheduled to host an eagerly anticipated webcast and conference call on Tuesday, December 19th at 8:30 am ET. The purpose of this highly anticipated event is to unveil the...

Tff Pharmaceuticals Inc

TFF Pharmaceuticals Inc Struggles with Growing Deficit in Recent Fiscal Period

Investing in the stock market can be a lucrative venture, but it comes with a fair share of risks. One of the significant considerations before taking any investment decision is to evaluate the company's financial status and its performance in the market. It is crucial to research and analyze the company's financial data before putting your money into any stock. Tff Pharmaceuticals Inc, a Healthcare sector company, has recorded a cumulative net loss of $-30 million during the 12 months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -130.07%.
This data indicates that investing in Tff Pharmaceuticals Inc's stock could be a risky move,
particularly for cautious investors. The negative ROA implies that the company is not generating sufficient profits relative to its total assets, which, in turn, has the potential to impact the company's long-term growth negatively. Additionally, in the Healthcare sector, 633 other companies had a higher return on assets, indicating that the competition is fierce.






 

Tff Pharmaceuticals Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com